A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer
Clinical trial NCT07332533 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07332533
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2032-06-30
- Enrollment
- 490
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.